결핵 검사 시장 : 검사 항목, 적응증, 검사장소, 최종사용자별 - 세계 예측(2025-2030년)

The Tuberculosis Testing Market was valued at USD 2.25 billion in 2023, expected to reach USD 2.38 billion in 2024, and is projected to grow at a CAGR of 5.88%, to USD 3.36 billion by 2030.

The scope of the Tuberculosis (TB) Testing market encompasses various diagnostic tests used to detect TB infections, including skin tests, blood tests, microscopy, nucleic acid tests, and culture-based tests. These tests are crucial in identifying active TB cases and latent TB infections, which aids in controlling the spread of this contagious disease. The necessity of TB testing lies in its application in both endemic and non-endemic regions to curb transmission and provide targeted treatment. They are essential in healthcare settings such as hospitals, clinics, and diagnostic laboratories, serving health departments and governments aiming for public health advancement. The market is driven by increasing incidence rates, a rising need for early and precise diagnostics, and advancements in test accuracy and speed. One of the latest potential opportunities within this sector arises from the integration of digital health technologies and AI for test interpretation, which can lead to quicker diagnosis and improved patient management. Market growth is influenced by factors such as government initiatives for TB eradication, rising awareness and screening programs, and increasing funding for R&D. Limitations include high costs, especially for advanced molecular tests, infrastructural challenges in low-resource settings, and the requirement for skilled personnel. A challenging factor is the latent nature of TB infections, which complicates timely diagnosis and public health responses. The best areas for innovation touch upon developing more accessible, cost-effective point-of-care tests that can be implemented in remote or underserved areas. This could include simplified test kits or mobile testing units. Research into vaccine development also represents a fertile ground for innovation. The market is adapting with an increase in partnerships between public health bodies and private enterprises to enhance testing infrastructure and outreach programs, making it a dynamic field ripe with both opportunities and challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tuberculosis Testing Market

The Tuberculosis Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the prevalence of tuberculosis worldwide
  • Growing tuberculosis awareness and control programs by government and regulatory authorities
  • High potential of point-of-care tuberculosis testing
• Market Restraints
  • High cost of advanced tuberculosis testings
• Market Opportunities
  • Ongoing developments in diagnostic technologies that enable faster diagnosis
  • Increasing number of tuberculosis diagnostic centers with advanced facilities
• Market Challenges
  • Skilled healthcare professionals proficient in administering and interpreting TB tests

Porter's Five Forces: A Strategic Tool for Navigating the Tuberculosis Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tuberculosis Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tuberculosis Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tuberculosis Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tuberculosis Testing Market

A detailed market share analysis in the Tuberculosis Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tuberculosis Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tuberculosis Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tuberculosis Testing Market

A strategic analysis of the Tuberculosis Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tuberculosis Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bruker Corporation, Cepheid by Danaher Corporation, Elisabeth Pharmacon, spol. s r.o., ELITech Group SAS, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Hologic Corporation, Lionex Diagnostics & Therapeutics GmbH, OSANG HEALTHCARE CO., LTD, PerkinElmer, Inc., SD Biosensor, INC., Siemens AG, Thermo Fisher Scientific, Inc., Trivitron Healthcare Private Limited, Tulip Diagnostics (P) Ltd, and Turklab A.S..

Market Segmentation & Coverage

This research report categorizes the Tuberculosis Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test, market is studied across Culture-Based Tests, Interferon-Gamma Release Assays, Mantoux Tuberculin Skin Test, Nucleic Acid Amplification Tests, and Smear Microscopy.
• Based on Indication, market is studied across Active TB Infection and Latent TB Infection.
• Based on Testing Location, market is studied across In-laboratory Testing and Point-of-Care Testing.
• Based on End User, market is studied across Diagnostic Laboratories, Government & Public Health Organizations, Hospital, and Research & Academic Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the prevalence of tuberculosis worldwide
    • 5.1.1.2. Growing tuberculosis awareness and control programs by government and regulatory authorities
    • 5.1.1.3. High potential of point-of-care tuberculosis testing
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of advanced tuberculosis testings
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing developments in diagnostic technologies that enable faster diagnosis
    • 5.1.3.2. Increasing number of tuberculosis diagnostic centers with advanced facilities
  • 5.1.4. Challenges
    • 5.1.4.1. Skilled healthcare professionals proficient in administering and interpreting TB tests
• 5.2. Market Segmentation Analysis
  • 5.2.1. Test: Growing usage of IGRA in diagnosing latent TB infection due to their non-invasive nature and effectiveness
  • 5.2.2. End User: High accessibility to tuberculosis testing through government and public health organizations to curb the spread of TB and achieve public health goals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tuberculosis Testing Market, by Test

• 6.1. Introduction
• 6.2. Culture-Based Tests
• 6.3. Interferon-Gamma Release Assays
• 6.4. Mantoux Tuberculin Skin Test
• 6.5. Nucleic Acid Amplification Tests
• 6.6. Smear Microscopy

7. Tuberculosis Testing Market, by Indication

• 7.1. Introduction
• 7.2. Active TB Infection
• 7.3. Latent TB Infection

8. Tuberculosis Testing Market, by Testing Location

• 8.1. Introduction
• 8.2. In-laboratory Testing
• 8.3. Point-of-Care Testing

9. Tuberculosis Testing Market, by End User

• 9.1. Introduction
• 9.2. Diagnostic Laboratories
• 9.3. Government & Public Health Organizations
• 9.4. Hospital
• 9.5. Research & Academic Institutions

10. Americas Tuberculosis Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Tuberculosis Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Tuberculosis Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Revvity Introduces Advanced Automation for Tuberculosis Testing, Enhancing Efficiency and Accuracy
  • 13.3.2. MedGenome Collaborates with Darshan GIVA Foundation to Enhance TB Diagnosis through Whole Genome Sequencing
  • 13.3.3. VinBrain Partners with Vietnam's National TB Screening Initiative to Combat Tuberculosis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Becton, Dickinson, and Company
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Bruker Corporation
• 6. Cepheid by Danaher Corporation
• 7. Elisabeth Pharmacon, spol. s r.o.
• 8. ELITech Group SAS
• 9. F. Hoffmann-La Roche AG
• 10. Fujifilm Holdings Corporation
• 11. Hologic Corporation
• 12. Lionex Diagnostics & Therapeutics GmbH
• 13. OSANG HEALTHCARE CO., LTD
• 14. PerkinElmer, Inc.
• 15. SD Biosensor, INC.
• 16. Siemens AG
• 17. Thermo Fisher Scientific, Inc.
• 18. Trivitron Healthcare Private Limited
• 19. Tulip Diagnostics (P) Ltd
• 20. Turklab A.S.